Track Actuate Therapeutics's total current liabilities ($4.7M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), ACTU shows a total current liabilities of $4.7M. That compares with $9.2M in the prior-year period — down 48.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ACTU's total current liabilities is now $4.7M (was $9.2M) — a 48.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Actuate Therapeutics is outperforming or lagging.
Tracking ACTU's total current liabilities over time shows whether Actuate Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $4.7M That compares with $9.2M in the prior-year period — down 48.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has Actuate Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $4.7M) with ownership activity and broader fundamentals.